Skip to main content

Drugs Made In America Acquisition Corp.

DMAAR
Exchange
Nasdaq
Industry
Blank Checks
SEC CIK
0002028614

No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.

Other share classesDMAADMAAU

13F holders, Q4 2025

Institutional positions in Drugs Made In America Acquisition Corp. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
32
+1 vs. Q3 2025
Shares held
16.9M
+14.2K (+0.1%) vs. Q3 2025
Total value
$3.02M
−$560.1K (−15.6%) vs. Q3 2025
New holders
3
4 more added
Sold out
2
6 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 32 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 19 institutionsQ2 2025: 24 institutionsQ3 2025: 32 institutionsQ4 2025: 32 institutionsQ1 2026: 35 institutionsQ2 2026: 28 institutions
Value heldQ4 2025: $3.02M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $1.72MQ2 2025: $2.22MQ3 2025: $3.71MQ4 2025: $3.02MQ1 2026: $872.3KQ2 2026: $1.27M
Institutions holding DMAAR and their total value by quarter
QuarterHoldersValue
Q2 202628$1.27M
Q1 202635$872.3K
Q4 202532$3.02M
Q3 202532$3.71M
Q2 202524$2.22M
Q1 202519$1.72M
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q3 2025.

Institutions holding DMAAR in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Polar Asset Management Partners Inc.1,900,000$355.9K0.01%00.0%Unchanged
Hudson Bay Capital Management LP1,800,000$284.2K0.00%00.0%Unchanged
Harraden Circle Investments, LLC1,500,000$280.9K0.05%00.0%Unchanged
Toronto Dominion Bank1,003,000$187.6K0.00%+3,000+0.3%Added
Aristeia Capital LLC881,716$165.1K0.00%00.0%Unchanged
Highbridge Capital Management LLC1,024,112$161.7K0.01%+40,512+4.1%Added
Mangrove Partners850,000$159.2K0.01%00.0%Unchanged
Linden Advisors LP850,000$147.6K0.00%00.0%Unchanged
Clear Street Group Inc.625,435$117.1K0.00%−33,658−5.1%Reduced
Shaolin Capital Management LLC600,000$112.4K0.00%+25,000+4.3%Added
Boothbay Fund Management, LLC570,000$106.8K0.00%00.0%Unchanged
Wolverine Asset Management LLC563,136$105.5K0.00%−20.0%Reduced
Glazer Capital, LLC536,852$101.0K0.00%−51,448−8.7%Reduced
LMR Partners LLP500,000$93.7K0.00%00.0%Unchanged
Westchester Capital Management, LLC500,000$79.0K0.00%00.0%Unchanged
Rivernorth Capital Management, LLC417,998$78.3K0.00%+100,000+31.4%Added
Whitebox Advisors LLC400,000$74.9K0.00%00.0%Unchanged
Alpine Global Management, LLC362,500$67.9K0.02%00.0%Unchanged
CNH Partners LLC380,314$60.1K0.00%−119,686−23.9%Reduced
Radcliffe Capital Management, L.P.325,100$56.5K0.00%00.0%Unchanged
Context Capital Management, LLC250,000$46.8K0.00%00.0%Unchanged
Heights Capital Management, Inc234,109$37.0K0.01%−55,193−19.1%Reduced
Bulldog Investors, LLP130,264$24.4K0.01%00.0%Unchanged
BNP Paribas Arbitrage, SA119,686$22.4K0.00%+119,686New
Schonfeld Strategic Advisors LLC117,480$22.0K0.00%−29,527−20.1%Reduced
DLD Asset Management, LP101,594$19.0K0.00%+101,594New
Quarry LP100,000$18.7K0.00%00.0%Unchanged
Verition Fund Management LLC100,000$15.8K0.00%00.0%Unchanged
Periscope Capital Inc.75,000$14.0K0.00%00.0%Unchanged
Readystate Asset Management LP50,000$7.89K0.00%00.0%Unchanged
Meteora Capital, LLC2,000$3750.00%+2,000New
CSS LLC31,250––00.0%Unchanged
Parallax Volatility Advisers, L.P.0$00.00%−87,926−100.0%Sold out
UBS Group AG0$00.00%−150−100.0%Sold out
Atw Spac Management LLC––––Not filed